Ozempic, approved for use in India staring September 25, 2025, may be priced from $191-$293.
“In a major development for diabetes and weight loss management, India’s drug regulator, Central Drugs Standard Control Organisation (CDSCO), has approved Ozempic (semaglutide) for use in adults with type 2 diabetes.”
“The official Indian pricing of Ozempic is yet to be confirmed. However, according to a Hindustan Times report, its weight-loss version Wegovy may cost Rs 17,000-26,000 per month, depending on dosage, while rival drug Mounjaro (tirzepatide) is priced at Rs 14,000-17,500. Prices may vary by city, pharmacy, and packaging, and are expected to drop after generics launch post-2026.”
See full article here.
